However, the catalytic activity of ENO1 and the glucose uptake in the hepatocellular carcinoma (HCC) cells is enhanced by granulin A. And, The agents targeting ENO1 are attracting attention as a novel cancer therapeutics 33. This evidence concerns the gene ENO1 and hepatocellular carcinoma.